Cravath Publishes Winter 2026 Issue of Alumni Journal
Publications
April 10, 2026
Cravath partner Daniel J. Cerqueira served as contributing editor of Legal 500’s 2026 “Mergers & Acquisitions Country Comparative Guide,” which was published in April 2026. The guide provides a pragmatic overview of M&A laws and regulations across a variety of jurisdictions. Together with Dan, partner Jin‑Kyu Baek authored the United States chapter of the guide, which reviews M&A trends, the current state of the market, and key considerations for companies and shareholders.
Activities
April 10, 2026
Cravath partners David J. Kappos and Sharonmoyee Goswami participated in the 33rd Annual Intellectual Property Law & Policy Conference, which was hosted by Fordham Law School from April 8‑10, 2026 in New York. Dave moderated a session on current developments in IP, which discussed AI litigation and the evolution of IP doctrine; remedies in technology litigation; territoriality, extraterritoriality, and the limits of judicial authority; institutional competition and the fragmentation of global IP adjudication; and courts as central actors in technology governance. Sharon participated in a session covering patent and frontier technologies. The discussion topics included: patent law and AI governance; recalibrating patentability for the AI era; inventorship and human control; patent linkage and regulatory coordination; and remedies in ecosystem‑based innovation markets.
Deals & Cases
April 10, 2026
Cravath represented the administrative agent, joint lead arranger and joint bookrunner in connection with a $2.5 billion revolving credit facility made available to Expedia Group, Inc., one of the world’s largest online travel companies. The transaction closed on March 27, 2026.
Activities
April 10, 2026
On April 9, 2026, Cravath partner G.J. Ligelis Jr. participated in the International Bar Association’s Asia Pacific Mergers & Acquisitions Conference, which was held April 9‑10, 2026 in Tokyo, Japan. G.J. spoke during a session entitled “The Art of the Deal – Navigating through the Negotiation of Common M&A Issues,” which explored the negotiation positions, perspectives and alternatives of M&A counsel across several jurisdictions, highlighting key strategies and pitfalls to avoid when developing the best available deal.
Activities
April 10, 2026
On March 31, 2026, Cravath partner Jennifer S. Leete participated in “Audit Committees, Special Committees and Internal Investigations 2026,” a program presented by the Practising Law Institute in New York. Jennifer spoke on a panel entitled “Regulatory and Financial Reporting Developments – What Audit Committee and Special Committee Members Need to Know,” which discussed recent developments at the SEC, recent enforcement actions involving financial reporting issues, including non‑GAAP issues and internal control matters, recent developments in revenue recognition and how to stay ahead of other recent accounting, reporting and regulatory developments.
Activities
April 08, 2026
In April 2026, Vault announced that Cravath was ranked No. 1 on its Vault Law 100, a ranking of the most prestigious law firms across the United States, for the eleventh consecutive year. The results of the annual list are based on surveys of more than 20,000 law firm associates. In publicizing its results, Vault highlighted comments from survey respondents who described the Firm as offering associates “real, hands‑on responsibility” with a “high degree of independence,” the opportunity to engage with work that is “almost entirely substantive” and “predominantly above what I understand is my ‘level’ from an industry standard” and to “build meaningful client relationships from day one.” Respondents were quoted noting Cravath’s “truly outstanding” training system and “very positive” associate‑partner relations. Writes Vault, “Cravath is known as one of the most elite law firms and has a strong reputation for its work in antitrust, banking and credit, capital markets, corporate governance, executive compensation and benefits, general litigation, M&A, securities litigation, tax, trusts and estates, and white collar defense.”
Publications
April 08, 2026
On April 7, 2026, Intellectual Asset Management (“IAM”) published an article written by Cravath partner David J. Kappos and associate Noa M. Ma entitled, “Why Global FRAND Rate‑Setting Must Require SEP Owner Consent.” The article discusses why courts should only set global FRAND royalty rates with patent owner consent, arguing that forced rate‑setting risks undermining the balance of rights that underpins SEP licensing.
Podcasts
April 07, 2026
Lee Cleland is a Managing Director at Alvarez & Marsal. In this episode of On Tax, he and Cravath partner and host Len Teti talk about how seizing opportunities throughout his career helped shape Lee’s professional journey, and his approach to building lasting client relationships. Lee also discusses his brief retirement and the chance to build a new team that brought him back into the field.
Deals & Cases
April 06, 2026
Cravath represented the underwriters in connection with the $2 billion registered notes offering of Hewlett Packard Enterprise Company, an industry leading technology company. The transaction closed on March 23, 2026.
Activities
April 06, 2026
Four Cravath attorneys were selected to serve on Law360’s 2026 Editorial Advisory Boards: partners Ryan J. Patrone (Capital Markets), Claudia J. Ricciardi (Mergers & Acquisitions) and Jihyun Chung (Private Equity) and of counsel Scott B. Reents (Legal Tech). As Editorial Advisory Board members, they will provide feedback on Law360’s coverage and expert insight on how best to shape future coverage.
Deals & Cases
April 06, 2026
Cravath represented Rogers Communications Inc. in connection with its $750 million registered fixed‑to‑fixed rate subordinated notes offering. Rogers Communications is Canada's leading communications, sports and entertainment company. The transaction closed on March 27, 2026.
Deals & Cases
April 06, 2026
Cravath represented the administrative agent, joint lead arrangers and joint bookrunners in connection with $1.35 billion of credit facilities made available to subsidiaries of Versigent Limited, a global leader in the design, development and manufacture of low voltage and high voltage electrical architectures and the holding company for Aptiv PLC’s Electrical Distribution Systems segment, which Aptiv PLC spun off into a separate, independent, publicly traded company. The proceeds were used to partially finance the spin‑off. The credit facilities consisted of a $500 million term loan facility and an $850 million revolving credit facility. The transaction closed on November 26, 2025.
Deals & Cases
April 02, 2026
Cravath represented Akastor ASA in connection with its indirect 50% owned affiliate HMH Holding Inc.’s initial public offering of 10,520,000 shares of its Class A common stock at $20.00 per share. The shares began trading on The Nasdaq Global Select Market on April 1, 2026, under the ticker symbol “HMH.” The transaction closed on April 2, 2026.
Publications
April 01, 2026
On March 31, 2026, Cravath published the latest edition of its Artificial Intelligence Developments Newsletter, which includes a high‑level review of activity across technical, regulatory, legal, and market areas of AI over the last month.
Activities
April 01, 2026
Cravath partners Jin‑Kyu Baek, Nicholas A. Dorsey and Lauren Roberta Kennedy were featured in the 2026 edition of “Practice Perspectives: Vault’s Guide to Legal Practice Areas,” which highlights the experiences of practicing lawyers in more than 20 different areas of the law and is published annually.
Deals & Cases
March 31, 2026
On March 31, 2026, Biogen Inc. and Apellis Pharmaceuticals, Inc. announced that the companies have entered into a definitive agreement under which Biogen has agreed to acquire all outstanding shares of Apellis for $41.00 per share in cash at closing, or approximately $5.6 billion. Apellis stockholders will also receive a nontransferable CVR for each Apellis share held, entitling the holder to receive two payments of $2 per share each, contingent on certain annual global net sales thresholds being met for SYFOVRE®. Cravath is representing Biogen in connection with the transaction.
Deals & Cases
March 27, 2026
Cravath represented Hasbro Inc. in connection with its $400 million registered notes offering. Hasbro, Inc., together with its subsidiaries, operates as a play and entertainment company. The transaction closed on March 12, 2026.
Activities
March 26, 2026
The Chambers USA Awards 2026 named Cravath a finalist in its Antitrust and Corporate/M&A practice area categories. The awards celebrate the achievements of leading law firms and lawyers operating across the United States, recognizing those who demonstrate excellence in legal practice, innovation and sustained performance at the highest level. The winners will be announced on June 11, 2026 at an awards ceremony in New York.
Activities
March 26, 2026
On March 20, 2026, Cravath partner G.J. Ligelis Jr. participated in the 38th Annual Tulane Corporate Law Institute, which was hosted by Tulane University Law School from March 19‑20 in New Orleans, Louisiana. The event featured discussions between M&A and securities practitioners, Delaware Supreme Court and Court of Chancery judiciary, corporate counsel and investment bankers on topics in M&A, corporate and securities law. G.J. spoke on a panel entitled “The Shareholder Proposal Process.”
Deals & Cases
March 26, 2026
Cravath represented the initial purchasers in connection with the $700 million 144A/Reg. S high‑yield senior notes offering of The Chemours Company a leading, global provider of performance chemicals. The transaction closed on March 12, 2026.
Celebrating 200 years of partnership. In 2019, we celebrated our bicentennial. Our history mirrors that of our nation. Integral to our story is our culture.
Attorney Advertising. ©2026 Cravath, Swaine & Moore LLP.